In contrast to GPx2, the expression of GPx1 or GPx3 mRNA expression in all BC subtypes was not correlated with patient survival duration (P > 0.05) (SI Appendix, Fig. S3 A and B). This evidence concerns the gene GPX3 and breast cancer.